Michael's team is trying to find out how or why it might have worked. They surprised the world last September when they showed the experimental vaccine cut the risk of infection by 31 percent over three years.
"It is very likely that this vaccine only worked for a short period of time," Michael said in a telephone interview. "It is a weak, a modest effect but something that we can build on".'
Read more...
No comments:
Post a Comment
Thanks for your comment it is much appreciated.